Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive drug allergy testing: an alternative viewpoint.

W J Pichler1

  • 1Division of Allergology, Clinic for Rheumatology and Clinical Immunology/Allergology Inselspital, University of Bern, CH 3010, Bern, Switzerland. werner.pichler@insel.ch

Toxicology
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2013
Same author

In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2013
Same author

Intravenous immunoglobulin in urticaria.

Journal of investigational allergology & clinical immunology·2013
Same author

Allergy workup of severe cutaneous adverse drug reactions: a light at the end of the tunnel?

The British journal of dermatology·2013
Same author

Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA.

Allergy·2012
Same author

Etiology and pathogenesis of adverse drug reactions.

Chemical immunology and allergy·2012

Drugs can trigger T-cell immune responses by non-covalently binding to MHC-peptide complexes, potentially causing drug allergies. This novel mechanism requires updated allergy testing methods.

Area of Science:

  • Immunology
  • Pharmacology
  • Dermatology

Background:

  • T- and B-cells traditionally recognize drugs as haptens bound to carrier molecules.
  • Emerging evidence suggests drugs may also stimulate T-cells via non-covalent binding to MHC-peptide complexes and T cell receptors.

Purpose of the Study:

  • To investigate the mechanism of T-cell stimulation by drugs through non-covalent binding to MHC-peptide complexes.
  • To analyze the functional characteristics of drug-reactive T cells and their role in drug-induced exanthems.
  • To evaluate the implications of this new model for predicting drug allergenicity.

Main Methods:

  • Functional analysis of drug-reactive T cells.
  • Assessment of T-cell cytokine secretion (e.g., IL-5) and cytotoxicity.

Related Experiment Videos

  • Immunohistochemical analysis of drug-induced skin reactions.

    • Main Results:

    • Drug-reactive T cells exhibit high IL-5 secretion and cytotoxic activity.
    • Both CD4(+) and CD8(+) T cells mediate drug-specific cytotoxicity.
    • This cytotoxicity may contribute to keratinocyte death in drug-induced exanthems.

    Conclusions:

    • Drugs can potentially stimulate T-cells through non-covalent interactions with MHC-peptide complexes and T cell receptors.
    • This mechanism offers a new explanation for drug allergies and drug-induced exanthems.
    • Current drug allergy testing requires revision to incorporate this novel immune stimulation pathway.